"O Hospital CUF Tejo, em Lisboa, disponibiliza uma vasta oferta de cuidados de saúde. Consulte os serviços e faça a sua marcação online."

During the past decade, Hospital CUF Tejo conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital CUF Tejo" #1 sponsor was "Bayer" with 2 trials, followed by "Amgen" with 1 trials sponsored, "Janssen Pharmaceutica N.V., Belgium" with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "Nektar Therapeutics" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital CUF Tejo" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hospital CUF Tejo" are "Arthritis, Psoriatic" (1 trials), "Carcinoma, Transitional Cell" (1 trials), "Diabetic Retinopathy" (1 trials), "Dyslipidemia" (1 trials) and "Melanoma" (1 trials). Many other conditions were trialed in "Hospital CUF Tejo" in a lesser frequency.

Most popular intervention types in "Hospital CUF Tejo" are "Drug" (5 trials), "Biological" (1 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Apalutamide" (1 trials), "Bempegaldesleukin" (1 trials), "Chemotherapy" (1 trials) and "Evolocumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital CUF Tejo" are 5 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital CUF Tejo". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hospital CUF Tejo, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital CUF Tejo, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".